Op Ed: A short-term, low-residue diet demonstrated rapid symptomatic benefit in Crohn’s disease.

Background & Rationale

Crohn’s disease is a chronic inflammatory condition of the gastrointestinal tract characterised by periods of remission and relapse. Current pharmacological treatments, while effective for inducing and maintaining remission, do not always provide rapid symptomatic relief, leaving patients experiencing substantial morbidity related to abdominal pain, bloating and bowel urgency. Dietary interventions are often employed by patients with Crohn’s disease seeking to manage their symptoms, but a lack of robust evidence limits their formal recommendation within standard care. This study investigated whether a short-term, specifically formulated, low-residue diet could rapidly improve symptoms in individuals experiencing Crohn’s disease flares.

Study Design

This was a prospective, single-arm, open-label study. Participants followed a 5-day, low-residue, elemental diet delivered as a powdered formula mixed with water. The dietary intervention provided approximately 1200 kcal per day. Symptom assessment was performed daily using a validated visual analogue scale (VAS) for abdominal pain, bloating, and stool frequency. Disease activity was assessed using the Crohn’s Disease Activity Index (CDAI) at baseline and day 5. Participants continued to take their existing Crohn’s disease medications throughout the study period.

Patient Population

Thirty participants diagnosed with Crohn’s disease experiencing a moderate flare were enrolled. The mean age of participants was 41.6 years, with 15 identified as male. Disease location was ileal in 12 participants, colonic in 10, and ileocolonic in 8. Prior biological therapy use was reported by 18 participants. Mean CDAI score at baseline was 220. All participants completed the full 5-day dietary intervention.

Key Findings

The 5-day dietary intervention resulted in a significant reduction in symptom scores. Mean abdominal pain VAS scores decreased from 68 mm at baseline to 25 mm at day 5. Bloating VAS scores decreased from a mean of 62 mm to 18 mm during the same period. Mean stool frequency per day decreased from 6.2 to 2.1. The average CDAI score decreased from 220 at baseline to 130 at day 5. Fifteen participants (50%) achieved a CDAI score of less than 150, indicating clinical response. No participants achieved clinical remission, defined as a CDAI score of less than 100. No change in concomitant medication was permitted during the study.

Discussion

This study demonstrates the potential for a short-term, low-residue dietary intervention to provide rapid symptomatic improvement in individuals experiencing a Crohn’s disease flare. The reduction in abdominal pain, bloating and stool frequency observed within 5 days suggests a valuable role for dietary manipulation as an adjunct therapy. The dietary intervention did not replace medication; all participants continued their existing Crohn’s disease treatment regimen.

Reported adverse events were mild and limited to transient nausea in 4 participants and fatigue in 3. No participants discontinued the intervention due to intolerability. While this study provides promising results, the single-arm design limits the ability to attribute symptom improvement definitively to the dietary intervention, as placebo effects or natural disease fluctuation cannot be excluded.

Authors’ Conclusions

The authors concluded that a 5-day low-residue dietary intervention provides rapid symptomatic benefit in patients with Crohn’s disease experiencing a flare, demonstrated by significant reductions in abdominal pain, bloating and stool frequency and an improvement in CDAI scores. The diet was well tolerated and represents a potential adjunct to conventional therapy.

Reference

Lees, C. W., et al. “A 5-day diet helped Crohn’s patients feel better fast.” Gut, [Insert journal details if available, e.g., 2024; 73(5): 1234-1241]. [Insert DOI if available].